https://www.selleckchem.com/pr....oducts/abbv-cls-484.
The development of high-throughput drug screening (HTS) using primary cultures provides a promising, clinically translatable approach to tailoring treatment strategies for patients with cancer. However, this has been challenging for solid tumors because of often limited amounts of tissue available. In most cases, in vitro expansion is required before HTS, which may lead to overgrowth and contamination by non-neoplastic cells. In this study, hematoxylin and eosin staining and immunohistochemical staining were performed on 129 cytopa
Like
Comment
Share
